Somatostatin and insulin infusion in the management of diabetic ketoacidosis.
The effect of low-dose insulin infusion (4.8 U/h) in diabetic ketoacidosis was compared to that of low-dose insulin infusion (4.8 U/h) plus somatostatin (500 microgram/h IV). Treatment with insulin only in 20 patients caused normalization of blood glucose levels within 6 hours and resolution of ketoacidosis within 5 hours. During insulin plus somatostatin infusion in 7 patients, blood glucose levels returned to normal within 4 hours and acidosis was reduced within 3 hours. Correction of acidosis is the most important problem in diabetic ketoacidosis: in the severest cases cardiovascular and cerebral complications may ensue. The data presented show that addition of somatostatin to treatment with low doses of insulin reduces and resolves acidosis in a shorter time while plasma levels of glucagon and GH were concomitantly reduced.
D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood; D003926:Diabetic Coma / Q000150:complications; D016883:Diabetic Ketoacidosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D013004:Somatostatin / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin